Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: Usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders

American Journal of Clinical Pathology

Volumn 136, Issue 4, 2011, Pages 625-630

  Venkataraman, Girish ^a,b   Aguhar, Christine ^a   Kreitman, Robert J ^a   Yuan, Constance M ^a   Stetler Stevenson, Maryalice ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

B cell lymphoproliferative disorders; CD103; CD123; Flow cytometry; Non Hodgkin lymphoma

Indexed keywords

CD103 ANTIGEN; CD123 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; FLOW CYTOMETRY; FOLLICULAR LYMPHOMA; HAIRY CELL LEUKEMIA; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; PRIORITY JOURNAL;

ANTIGENS, CD; CELL SEPARATION; DIAGNOSIS, DIFFERENTIAL; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; INTEGRIN ALPHA CHAINS; INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT; LEUKEMIA, HAIRY CELL; LYMPHOPROLIFERATIVE DISORDERS; TUMOR MARKERS, BIOLOGICAL;

EID: 80053532947     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPKUM9J4IXCWEU     Document Type: Article

References (13)

1. Matutes E, Morilla R, Owusu-Ankomah K, et al. The immunophenotype of hairy cell leukemia (HCL): proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. Leuk Lymphoma. 1994;14(suppl 1):57-61. (Pubitemid 24282594)
2. Robbins BA, Ellison DJ, Spinosa JC, et al. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood. 1993;82:1277-1287. (Pubitemid 23254004)
3. Del Giudice I, Matutes E, Morilla R, et al. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes. Haematologica. 2004;89:303-308. (Pubitemid 38788414)
4. Moretti S, Lanza F, Dabusti M, et al. CD123 (interleukin 3 receptor alpha chain). J Biol Regul Homeost Agents. 2001;15:98-100. (Pubitemid 32492735)
5. Munoz L, Nomdedeu JF, Lopez O, et al. Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies. Haematologica. 2001;86:1261-1269. (Pubitemid 34016712)
6. Sanchez ML, Almeida J, Vidriales B, et al. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Leukemia. 2002;16:1460-1469.
7. Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008.
8. Stetler-Stevenson M, Ahmad E, Barnett D, et al. Clinical and Laboratory Standards Institute. Clinical flow cytometric analysis of neoplastic hematolymphoid cells; Approved guideline. Wayne, PA: Clinical and Laboratory Standards Institute; 2005. CLSI document H43-A2.
9. Jasper GA, Arun I, Venzon D, et al. Variables affecting the quantitation of CD22 in neoplastic B cells [published online ahead of print September 24, 2010]. Cytometry B Clin Cytom. 2011;80:83-90. doi:10.1002/cyto.b.20567.
10. Borowitz MJ, Bray R, Gascoyne R, et al. US-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation. Cytometry. 1997;30:236-244.
11. Greig B, Oldaker T, Warzynski M, et al. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: recommendations for training and education to perform clinical flow cytometry. Cytometry. 2007;72(Suppl 1):S23-S33. (Pubitemid 350194345)
12. Dong HY, Weisberger J, Liu Z, et al. Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders: hairy cell leukemia and its mimics. Am J Clin Pathol. 2009;131:586-595.
13. Fromm JR. Flow cytometric analysis of CD123 is useful for immunophenotyping classical Hodgkin lymphoma [published online ahead of print August 31, 2010]. Cytometry B Clin Cytom. 2011;80:91-99. doi:10.1002/cyto.b. 20561.